Shares of Sensyne Health PLC (LON:SENS – Get Free Report) dropped 33.3% on Tuesday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). Approximately 4,449,142 shares traded hands during trading, an increase of 29% from the average daily volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).
Sensyne Health Stock Down 33.3 %
The firm has a 50 day moving average of GBX 0.35 and a 200-day moving average of GBX 0.35. The company has a debt-to-equity ratio of 6.02, a current ratio of 2.26 and a quick ratio of 2.26. The stock has a market capitalization of £582,624.00 and a P/E ratio of -0.02.
About Sensyne Health
Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.
Read More
- Five stocks we like better than Sensyne Health
- What is the Nikkei 225 index?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Financial Services Stocks Investing
- Undervalued UnitedHealth Group Won’t Be For Long
- When to Sell a Stock for Profit or Loss
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensyne Health and related companies with MarketBeat.com's FREE daily email newsletter.
